A Unique Clade of SARS-CoV-2 Viruses is Associated with Lower Viral Loads in Patient Upper Airways
Open accessPreprint — published as 10.1016/j.ebiom.2020.103112 · Paper page
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Background: The rapid spread of SARS-CoV-2, the causative agent of Coronavirus disease 2019 (COVID- 19), has been accompanied by the emergence of distinct viral clades, though their clinical significance remains unclear. Here, we aimed to investigate the phylogenetic characteristics of SARS-CoV-2 infections in Chicago, Illinois and assess their relationship to clinical parameters. Methods: We performed whole-genome sequencing of SARS-CoV-2 isolates collected from COVID-19 patients in a Chicago healthcare system in mid-March, 2020. Using these and other publicly available sequences, we performed phylogenetic, phylogeographic, and phylodynamic analyses. Patient data was assessed for correlations between demographic or clinical characteristics and virologic features. Findings: The 88 SARS-CoV-2 genome sequences in our study separated into three distinct phylogenetic clades. Clade 1 was most closely related to viral sequences from New York, and showed evidence of rapid expansion across the US, while Clade 3 was most closely related to those in Washington state. Clade 2 was localized primarily to the Chicago area with limited evidence of expansion elsewhere. At the time of diagnosis, patients infected with Clade 1 viruses had significantly higher average viral loads in their upper airways relative to patients infected with Clade 2 viruses, independent of time to symptom onset and disease severity. Interpretation: These results show that multiple variants of SARS-CoV-2 are circulating in the Chicago area that differ in their relative viral loads in patient upper airways. These data suggest that differences in virus genotype impact viral load and may in turn influence viral transmission and spread. Funding: Dixon Family Translational Research Award, Northwestern University Clinical and Translational Sciences Institute (NUCATS), National Institute of Allergy and Infectious Diseases (NIAID)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies correlated D614G mutation with higher viral load in nasopharyngeal aspirate, supporting the advantage in transmission, fitness advantage, and enhanced infectivity in COVID-19 patients [25].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209 · cited 1×
“453 (19) software and manually edited using MEGA v6.”
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Guindon, S., Dufayard, J.-F., Lefort, V., Anisimova, M., Hordijk, W., & Gascuel, O. (2010) · Systematic Biology · doi:10.1093/sysbio/syq010 · Cited by 18,376 · cited 1×
“11 (21), assessing the tree topology with the Shimodaira–Hasegawa approximate likelihood ratio test (SH-aLRT) (22) with 1000 replicates.”
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575 · cited 2×
“Ancestral reconstruction of these global sequences showed low divergence of these samples from those first sequenced in Wuhan, China (Figure 3A).”
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894 · cited 1×
“11 (21), assessing the tree topology with the Shimodaira–Hasegawa approximate likelihood ratio test (SH-aLRT) (22) with 1000 replicates.”
Minimap2: Pairwise alignment for nucleotide sequences
Li, H. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty191 · Cited by 14,807
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
BEAST 2: a software platform for Bayesian evolutionary analysis
Bouckaert, R., Heled, J., Kühnert, D., Vaughan, T., Wu, C.-H., Xie, D., Suchard, M. A., Rambaut, A., & Drummond, A. J. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003537 · Cited by 6,527 · cited 1×
“2 (24) to estimate the date and location of the most recent common ancestors (MRCA) as well as to estimate the rate of evolution of the virus.”
Research works printed but not linked: 1
- Oxford Nanopore Technologies. https://community.nanoporetech.com (accessed April 27, 2020).
Cited by
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Spike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900
Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibilityPreprint
Shi, P., Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., et al. (2020) · bioRxiv · doi:10.21203/rs.3.rs-70482/v1 · Cited by 42
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear
Grubaugh, N. D., Hanage, W. P., & Rasmussen, A. L. (2020) · Cell · doi:10.1016/j.cell.2020.06.040 · Cited by 353
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityPreprint
Volz, E., Hill, V., McCrone, J., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20166082 · Cited by 313
“Combined with epidemiological observations of disparities in viral loads in the upper respiratory tract(Lorenzo-Redondo et al., 2020; Wölfel et al., 2020), these results are suggestive of a transmission-mediated fitness differential between Spike 614 variants.”
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Thakur, V., Bhola, S., Thakur, P., Patel, S. K. S., Kulshrestha, S., Ratho, R. K., & Kumar, P. (2022) · Infection · doi:10.1007/s15010-021-01734-2 · Cited by 195
“Studies correlated D614G mutation with higher viral load in nasopharyngeal aspirate, supporting the advantage in transmission, fitness advantage, and enhanced infectivity in COVID19 patients [25].”
BackgroundEffects of SARS-CoV-2 variants on vaccine efficacy and response strategies
Bian, L., Gao, F., Zhang, J., He, Q., Mao, Q., Xu, M., & Liang, Z. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1903879 · Cited by 185
“A higher viral load was also detected in the nasopharynx of patients infected with the G614 virus than in those infected with the D614 virus [27], which suggests that the D614G substitution”
BackgroundEvolutionary trajectory of SARS-CoV-2 and emerging variants
Singh, J., Pandit, P., McArthur, A. G., Banerjee, A., & Mossman, K. L. (2021) · Virology Journal · doi:10.1186/s12985-021-01633-w · Cited by 171
“Preliminary evidence suggests that D614G increases viral susceptibility to neutralization [113], with uncertain impacts on disease severity [104, 114, 115].”
BackgroundFrom delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants
PAPANIKOLAOU, V. S., Chrysovergis, A., Ragos, V., Tsiambas, E., Katsinis, S., Manoli, A., Papouliakos, S. M., Roukas, D., Mastronikolis, S. N., Peschos, D., et al. (2022) · Gene · doi:10.1016/j.gene.2021.146134 · Cited by 159
“…spectrum of specific point nucleotide changes -including missense, synonymous and nonsynonymous deletions and single amino acid mutations – creates a SARS-CoV-2 genomic mosaic that critically influences basic pandemic clinic-molecular parameters (Sungnak et al., 2020; Lorenzo-Redondo et al., 2020).”
Long, S. W., Olsen, R. J., Christensen, P. A., Bernard, D. W., Davis, J. J., Shukla, M. P., Nguyen, M., Saavedra, M. O., Yerramilli, P., Pruitt, L., et al. (2020) · mBio · doi:10.1128/mbio.02707-20 · Cited by 151
“reported that patients infected with strains having spike protein Gly614 variant 377 have, on average, higher virus loads on initial diagnosis (66-70).”
Groves, D. C., Rowland‐Jones, S., & Angyal, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.109 · Cited by 137
“Similarly, studies in a cohort in Chicago showed that strains expressing G614 were associated with higher airway viral loads but not with worse disease outcomes [10].”
An Effective COVID-19 Vaccine Needs to Engage T Cells
Sauer, K., & Harris, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.581807 · Cited by 90
Akkız, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.636532 · Cited by 85
“The researchers concluded that there are multiple variants of the virus in the USA with different viremia levels and transmission potential (20).”
BackgroundResultInfluentialHospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19
Nakamichi, K., Shen, J. Z., Lee, C. S., Lee, A., Roberts, E. A., Simonson, P. D., Roychoudhury, P., Andriesen, J. G., Randhawa, A. K., Mathias, P. C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82850-9 · Cited by 69
SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variantPreprint
Yadav, P., Mohandas, S., Shete, A., Nyayanit, D. A., Gupta, N., Patil, D., Sapkal, G., Potdar, V., Kadam, M., Kumar, A., et al. (2021) · bioRxiv · doi:10.1101/2021.05.05.442760 · Cited by 51
“1 variant is known to enhance the virus infectivity and transmissibility, it has been reported not to cause severe disease in humans [18, 19].”
BackgroundSARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivoPreprint
Hou, Y. J., Chiba, S., Halfmann, P., et al. (2020) · bioRxiv · doi:10.1101/2020.09.28.317685 · Cited by 50
Zhao, Z., Sokhansanj, B. A., Malhotra, C., Zheng, K., & ROSEN, G. L. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008269 · Cited by 56
“Viral spread is suspected to be due to primary exposure of an individual from China to Washington state, designating this case as “WA1” [17, 60].”
BackgroundInfluentialBiological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Hoteit, R., & Yassine, H. M. (2022) · Vaccines · doi:10.3390/vaccines10060919 · Cited by 51
Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya
Githinji, G., de Laurent, Z. R., Mohammed, K. S., Omuoyo, D. O., Macharia, P. M., Morobe, J. M., Otieno, E. G., Kinyanjui, S., Agweyu, A., Maitha, E. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25137-x · Cited by 44
Poustforoosh, A., Hashemipour, H., Tüzün, B., Azadpour, M., Faramarz, S., Pardakhty, A., Mehrabani, M., & Nematollahi, M. H. (2022) · Current Microbiology · doi:10.1007/s00284-022-02921-6 · Cited by 46
Tracking the onset date of the community spread of SARS-CoV-2 in western countries
Delatorre, E. O., Mir, D., Gräf, T., & Bello, G. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200183 · Cited by 92
On the genetics and immunopathogenesis of COVID-19
Jacob, C. O. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108591 · Cited by 41
“During March 2020 both variants could be identified circulating in the population [29,34].”
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran
Salehi-Vaziri, ., Jalali, T., Farahmand, B., Fotouhi, F., Banifazl, M., Pouriayevali, M. H., Larijani, M. S., Afzali, N., & Ramezani, A. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04221-6 · Cited by 31
“There have been some evidences that the rapid spread of G614 was due to its more infectious potency than D614 and a higher levels of viral RNA has been assessed in the clinical samples from G614 infections[38, 39].”
BackgroundJaroszewski, L., Iyer, M., Alisoltani, A., et al. (2020) · bioRxiv · doi:10.1101/2020.08.10.244756 · Cited by 28
“This is fairly typical for RNA viruses and it cannot be automatically interpreted as a sign that the disease it is causing is changing [2], but the first epidemiological data indicating that more transmissible viral strains are emerging [3] and preliminary experimental analyses hinting at such changes have appeared [4…”
ResultParvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107413 · Cited by 21
Gunadi, G., Wibawa, H., Marcellus, Hakim, M. S., Daniwijaya, E. W., Rizki, L. P., Supriyati, E., Nugrahaningsih, D. A. A., Afiahayati, Siswanto, S., et al. (2020) · PeerJ · doi:10.7717/peerj.10575 · Cited by 24
Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal
Borges, V., Isidro, J., Martins, H. C., Duarte, S., Mota‐Vieira, L., Leite, R. B., Gordo, I., Caetano, C., Nunes, B., Sá, R., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1844552 · Cited by 29
“As previously seen [13,28,29], we observed that samples with Spike G614 had Ct values (mean = 22.2; n = 844) lower than those with D614 viruses (mean = 22.9; n = 96), although without statistical signi fi cance (Figure S4).”
BackgroundResultInfluentialRouchka, E. C., Chariker, J. H., Alejandro, B. S., Adcock, R. S., Singhal, R. A., Ramírez, J. A., Palmer, K. E., Lasnik, A. B., Carrico, R., Arnold, F. W., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95197-y · Cited by 23
Eskier, D., Suner, A., Karakülah, G., et al. (2020) · bioRxiv · doi:10.1101/2020.06.15.153239 · Cited by 16
Intra-host evolution during SARS-CoV-2 persistent infectionPreprint
Voloch, C., F, R. D. S., de Almeida, L. D., et al. (2020) · medRxiv · doi:10.1101/2020.11.13.20231217 · Cited by 15
Krajcar, N., Marić, L. S., Šurina, A., Filipović, S. K., Trkulja, V., Roglić, S., & Tešović, G. (2020) · Croatian Medical Journal · doi:10.3325/cmj.2020.61.491 · Cited by 21
Variation and multilevel selection of SARS‐CoV‐2
Blackstone, N. W., Blackstone, S. R., & Berg, A. T. (2020) · Evolution · doi:10.1111/evo.14080 · Cited by 21
“For example, are the SARS-CoV-2 genome sequences of infected individuals on the Diamond Princess similar or different from those that circulated in New York City early in the pandemic (cf., Korber et al. 2020; Lorenzo-Redondo et al. 2020)?”
BackgroundMaking sense of spike D614G in SARS-CoV-2 transmission
Shi, A. C., & Xie, X. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1893-9 · Cited by 21
“…higher levels of viral RNA were detected in nasopharyngeal swabs from the G614 virus-infected patients than those from the D614 virus-infected individuals (Lorenzo-Redondo et al., 2020), suggesting that the D614G substitution may increase viral fitness in humans without causing more severe disease.”
BackgroundMustapha, J. O., Abdullahi, I. N., Ajagbe, O., Emeribe, A. U., Fasogbon, S. A., Onoja, S. O., Ugwu, C. E., Umeozuru, C. M., Ajayi, F. O., Tanko, W. N., et al. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05951 · Cited by 18
RetractedCandidate Multi-Epitope Vaccine against Corona B.1.617 Lineage: In Silico Approach
Seadawy, M. G., Zekri, A. N., Saeed, A. A., San, E. J., & Ageez, A. M. (2022) · Life · doi:10.3390/life12111715 · Cited by 12
“Another reports pa ients carrying strains with G have higher irway viral loads but not ith severe disease symptoms [37].”
BackgroundMolecular epidemiology in the HIV and SARS-CoV-2 pandemics
Lorenzo-Redondo, R., Ozer, E. A., Achenbach, C. J., D’Aquila, R. T., & Hultquist, J. F. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000660 · Cited by 22
Self-citationWruck, W., & Adjaye, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-00267-w · Cited by 19
The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike
Guo, C.-X., Tsai, S.-J., Ai, Y., et al. (2020) · bioRxiv · doi:10.1101/2020.12.08.417022 · Cited by 9
First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity
Zrelovs, Ņ., Ustinova, M., Silamiķelis, I., Birzniece, L., Megnis, K., Rovīte, V., Freimane, L., Silamiķele, L., Ansone, L., Pjalkovskis, J., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.626000 · Cited by 10
Al-Qahtani, A. A. (2022) · Journal of International Medical Research · doi:10.1177/03000605221086433 · Cited by 8
“SARS-CoV-2 data from Chicago and Washington also revealed the D614G mutation to be associated with increased viral load but not severity or poor outcomes.(84) A correlation between D614G and the CFR in various countries was reported,(85) while Legros et al.”
BackgroundGenomic Signatures of SARS-CoV-2 Associated with Patient Mortality
Dumonteil, E., Fusco, D. N., Drouin, A. C., & Herrera, C. P. (2021) · Viruses · doi:10.3390/v13020227 · Cited by 8
“Similarly, a G/T variant in the Open reading frame 1ab (Orf1ab) gene has been associated with symptomatic and asymptomatic infections, respectively, in a small cohort of 152 patients [13], and some viral clades from Chicago have been associated with differences in viral loads [14].”
BackgroundHealthy humans can be a source of antibodies countering COVID-19
Velappan, N., Nguyen, H. B., Micheva‐Viteva, S., Bedinger, D., Ye, C., Mangadu, B., Watts, A. J., Meagher, R. J., Bradfute, S. B., Hu, B., et al. (2022) · Bioengineered · doi:10.1080/21655979.2022.2076390 · Cited by 7
“At the time of these experiments, the predominant virus variant carried an aspartic acid (D) to glycine (G) mutation at amino acid position 614 of spike protein (D614G variant) [62,63], therefore our antibodies were also tested for recognition for D614G spike.”
BackgroundZhang, M., Gong, Y., & Jiao, S. (2022) · Future Virology · doi:10.2217/fvl-2021-0100 · Cited by 7
Giorgi, E. E., Bhattacharya, T., Fischer, W. M., Yoon, H., Abfalterer, W., & Korber, B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.29.428535 · Cited by 5
Outcomes associated with SARS-CoV-2 viral clades in COVID-19
Nakamichi, K., Shen, J. Z., Lee, C. S., et al. (2020) · medRxiv · doi:10.1101/2020.09.24.20201228 · Cited by 6
Borges, V., Isidro, J., Cortes-Martins, H., et al. (2020) · medRxiv · doi:10.1101/2020.08.10.20171884 · Cited by 5
“As previously seen (Korber et al, 2020; Lorenzo-Redondo et al, 2020; Wagner et al, 2020), we observed that infected individuals with Spike G614 had Ct values (mean=22.2; n=844) lower than those infected with D614 viruses (mean=22.9; n=96), still without statistical significance by Wilcoxon Rank Sum…”
ResultInfluentialINSIGHT OF PANDEMIC COVID-19: DEVELOPMENTS AND CHALLENGES
Muneer, M. A., Arshad, M., Abbas, G., Arshad, M., Munir, K., Iqbal, A., Mustafa, A., Amin, Q., Khan, M. A., Qureshi, R. A., et al. (2023) · Pakistan Journal of Science · doi:10.57041/pjs.v75i1.831 · Cited by 4
Characterizing SARS-CoV-2 Spike Sequences Based on Geographical Location
Ali, S., Bello, B., Tayebi, Z., & Patterson, M. (2023) · Journal of Computational Biology · doi:10.1089/cmb.2022.0391 · Cited by 3
“…neutral effects, a few that occur in major proteins—be it, addition, substitution, or deletion—are critical to viral evolution, genomic stability, transmissibility, antigenicity, virulence, adaptation, and escape from the host immune response (Lorenzo-Redondo et al, 2020; Pachetti et al, 2020).”
Mutation Landscape of SARS COV2 in AfricaPreprint
Nassir, A. A., Musanabaganwa, C., & Mwikarago, I. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.20.423630 · Cited by 2
“D614G is more infectious than the wild type sequence as it binds more efficiently to the human ACE2 receptor (Hu et al., 2020; Korber et al., 2020; Lorenzo-Redondo et al., 2020; Ozono et al., 2020; Wagner et al., 2020).”
BackgroundSARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model
Yadav, P. D., Mohandas, S., Shete, A. M., Nyayanit, D. A., Gupta, N., Patil, D. Y., Sapkal, G. N., Potdar, V. A., Kadam, M., Kumar, A., et al. (2022) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2021.0080 · Cited by 55
Transmission of SARS-COV-2 from China to Europe and West Africa: a detailed phylogenetic analysis
Wruck, W., & Adjaye, J. (2020) · bioRxiv · doi:10.1101/2020.10.02.323519 · Cited by 3
“However, others find evidence for higher transmissibility and also higher viral-load but no evidence for higher disease severity (1), (25), (26).”
BackgroundCluzel, N., Lambert, A., Maday, Y., et al. (2020) · bioRxiv · doi:10.1101/2020.07.31.230607 · Cited by 2
“For this reason, several previous analyses have suggested that this mutation has an important role in the spread of the virus [41,42].”
Long, S., Olsen, R., Christensen, P. A., Bernard, D. W., Davis, J. J., Shukla, M., Nguyen, M., Saavedra, M., Yerramilli, P., Pruitt, L., et al. (2020) · medRxiv · doi:10.1101/2020.09.22.20199125 · Cited by 2
“18 have, on average, higher virus loads on initial diagnosis (66-70).”
Cluzel, N., Lambert, A., Maday, Y., Turinici, G., & Danchin, A. (2020) · Comptes Rendus Biologies · doi:10.5802/crbiol.16 · Cited by 7
Ibrahim, F., Natasha, A., Yasmon, A., Fithriyah, F., Karuniawati, A., Rahmawaty, R. G., Saharman, Y., & Sudarmono, P. (2022) · F1000Research · doi:10.12688/f1000research.122019.1
“, who noted that the D614G mutations did not correlate with more severe outcomes.(19,20) Our study showed a ti/tv ratio decline between the GH and GK clades.”
BackgroundPracticability of serological assays for upscaling COVID-19 laboratory testing in Africa
Abdullahi, I. N., Emeribe, A. U., Animasaun, O. S., Ajagbe, O., Nwofe, J. O., Ghamba, P. E., Umeozuru, C. M., Asiegbu, E. C., Tanko, W. N., Gadama, A. S., et al. (2021) · Journal of Global Health · doi:10.7189/jogh.11.03038
Virus genomics as a clinical and epidemiological tool
Petrone, M. E. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103141
“They were unsuccessful in fi nding a statistically signi fi cant link between virus clade and disease severity [1], and their fi ndings are largely consistent with the literature [5,7].”
InfluentialThe emergence of inter-clade hybrid SARS-CoV-2 lineages revealed by 2D nucleotide variation mappingPreprint
Wang, H.-L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.13.338038
A Review on D 614G Mutation with Bangladesh Scenario
Akram, A., Khan, M., Monir, M. B. B., et al. (2020) · Advances in Infectious Diseases · doi:10.4236/aid.2020.103024
“These observations are supported by two independent studies: 175 COVID-19 patients from Seattle, WA (Wagner et al., 2020) and 88 COVID-19 patients from Chicago, IL (Lorenzo-Redondo et al., 2020) in the United States [7] [8].”
Metadata
- Authors
- Lorenzo-Redondo, R., Nam, H. H., Roberts, S. C., Simons, L. M., Jennings, L. J., Qi, C., Achenbach, C. J., Hauser, A. R., Ison, M. G., Hultquist, J. F., & Ozer, E. A.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Hultquist, Judd F.
- Ozer, Egon A.
- ORCID
- Venue
- EBioMedicine
- Publisher
- openRxiv
- Published
- 2020-05-26
- Volume
- 62
- Pages
- 103112-103112
- ISSN
- 2352-3964 (ISSN-L)
- PMC
- PMC7274239
- OpenAlex
- W3098794734
- Cited by
- 111
- References
- 33
- Citations by year
- 2024: 7 · 2023: 7 · 2022: 22 · 2021: 40 · 2020: 35
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- EBioMedicine (publishedVersion, cc-by-nc-nd)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by-nc-nd)
- Galter Health Sciences Library, Northwestern University
- Funders
- Gilead Sciences (COVID-19)
- Dhont Family Foundation
- Northwestern University (T32 AI095207)
- National Institutes of Health (AI04831, K24 AI04831, UL1TR001422, COVID-19, AI135964, UL1TR002389, UL1TR001863)
- Office of the Provost, University of South Carolina
- Quest High Performance Computing
- National Institute of Allergy and Infectious Diseases (K22AI136691, T32AI095207, U19AI135964)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, COVID-19 pandemic, viral clades, phylogenetic analysis, viral load, upper airway, phylodynamics, phylogeography, whole genome sequencing, Chicago, viral variants, disease severity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.